Delaware | 25-1701361 | |
(State or Other Jurisdiction of Incorporation) |
(I.R.S. Employer Identification No.) |
Exhibit | ||
No. | Description | |
23.1
|
Consent of KPMG LLP | |
99.1
|
Audited financial statements of Triant Holdings, Inc. for the twelve months ended December 31, 2007 and unaudited financial statements of Triant Holdings, Inc. the six months ended June 30, 2008 | |
99.2
|
The unaudited pro forma condensed combined balance sheet of PDF Solutions Inc. and Triant Holdings, Inc. as of June 30, 2008. The unaudited pro forma condensed combined statements of operations of PDF Solutions Inc. and Triant Holdings, Inc. for the twelve months ended December 31, 2007 and the six months ended June 30, 2008. |
3
PDF SOLUTIONS, INC. |
||||
By: | /s/ Keith A. Jones | |||
Keith A. Jones | ||||
Vice President, Finance and Chief Financial Officer |
||||
4
/s/ KPMG LLP
|
||
Chartered Accountants |
||
Vancouver, Canada November 7, 2008 |
Page | ||
2 | ||
3 | ||
4 | ||
5 | ||
6 | ||
14 | ||
15 | ||
16 | ||
17 | ||
18 | ||
19 |
June 30, | December 31, | |||||||
2008 | 2007 | |||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 410,153 | $ | 995,106 | ||||
Restricted cash (note 7 (b)) |
50,000 | | ||||||
Accounts receivable: |
||||||||
Trade |
526,485 | 598,815 | ||||||
Other |
73,218 | 144,662 | ||||||
Inventory (note 3) |
151,389 | 170,565 | ||||||
Prepaid expenses |
147,161 | 183,408 | ||||||
1,358,406 | 2,092,556 | |||||||
Property, plant and equipment |
162,262 | 183,643 | ||||||
$ | 1,520,668 | $ | 2,276,199 | |||||
Liabilities and Shareholders Equity |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 18,975 | $ | 109,718 | ||||
Accrued liabilities |
282,933 | 282,422 | ||||||
Deferred revenue |
204,167 | 146,582 | ||||||
506,075 | 538,722 | |||||||
Shareholders equity: |
||||||||
Capital stock: |
||||||||
Preferred shares: |
||||||||
Authorized: No maximum, without par value
Issued and outstanding: June 30, 2008 and December
31, 2007 - nil |
||||||||
Common shares: |
||||||||
Authorized: No maximum, without par value
Issued and outstanding: June 30, 2008 - and December
31, 2007 - 4,170,399 |
36,809,322 | 36,809,322 | ||||||
Contributed surplus |
3,440,680 | 3,399,100 | ||||||
Deficit |
(39,235,409 | ) | (38,470,945 | ) | ||||
1,014,593 | 1,737,477 | |||||||
$ | 1,520,668 | $ | 2,276,199 | |||||
/s/ Robert Heath
|
Director | /s/ Richard B. Grogan | Director | |||
Robert Heath
|
Richard B. Grogan |
2
Six months ended | ||||||||
June 30, | ||||||||
2008 | 2007 | |||||||
Revenue: |
||||||||
Licenses and products |
$ | 849,949 | $ | 413,721 | ||||
Services and maintenance |
1,156,922 | 1,418,003 | ||||||
2,006,871 | 1,831,724 | |||||||
Cost of revenue |
568,694 | 514,043 | ||||||
Gross margin |
1,438,177 | 1,317,681 | ||||||
Operating expenses: |
||||||||
Selling, general and administrative |
1,266,165 | 1,387,456 | ||||||
Research and development |
962,461 | 1,037,212 | ||||||
2,228,626 | 2,424,668 | |||||||
Loss from operations |
(790,449 | ) | (1,106,987 | ) | ||||
Interest and other income |
9,766 | 39,241 | ||||||
Foreign exchange gains (losses) |
16,219 | (110,206 | ) | |||||
Gain on sale of marketable securities |
| 334,143 | ||||||
Net and comprehensive
loss for the period |
$ | (764,464 | ) | $ | (843,809 | ) | ||
Loss per common share |
$ | (0.18 | ) | $ | (0.20 | ) | ||
Weighted average number of
common shares outstanding |
4,170,399 | 4,158,008 | ||||||
3
Common shares | Contributed | |||||||||||||||||||
Shares | Amount | surplus | Deficit | Total | ||||||||||||||||
Balance, December 31, 2006 |
4,140,789 | $ | 36,739,395 | $ | 3,306,606 | $ | (36,694,004 | ) | $ | 3,351,997 | ||||||||||
Issued for cash: |
||||||||||||||||||||
Exercises of stock options |
29,610 | 50,985 | | | 50,985 | |||||||||||||||
Transfer from contributed surplus
to share capital on exercise of options |
| 18,942 | (18,942 | ) | | | ||||||||||||||
Stock-based compensation |
| | 111,436 | | 111,436 | |||||||||||||||
Net and comprehensive
loss for the year |
| | | (1,776,941 | ) | (1,776,941 | ) | |||||||||||||
Balance, December 31, 2007 |
4,170,399 | 36,809,322 | 3,399,100 | (38,470,945 | ) | 1,737,477 | ||||||||||||||
Stock-based compensation (note 4) |
| | 41,580 | | 41,580 | |||||||||||||||
Net and comprehensive
loss for the period |
| | | (764,464 | ) | (764,464 | ) | |||||||||||||
Balance, June 30, 2008 |
4,170,399 | $ | 36,809,322 | $ | 3,440,680 | $ | (39,235,409 | ) | $ | 1,014,593 | ||||||||||
4
Six months ended | ||||||||
June 30, | ||||||||
2008 | 2007 | |||||||
Cash provided by (used in): |
||||||||
Operations: |
||||||||
Net loss and other comprehensive
income for the period |
$ | (764,464 | ) | $ | (843,809 | ) | ||
Items not affecting cash: |
||||||||
Amortization |
27,830 | 23,326 | ||||||
Stock-based compensation (note 4) |
41,580 | 52,783 | ||||||
Gain on sale of marketable
securities |
| (334,143 | ) | |||||
Changes in operating assets and
liabilities (note 5) |
166,550 | (327,395 | ) | |||||
Net cash (used in)
operating activities |
(528,504 | ) | (1,429,238 | ) | ||||
Financing: |
||||||||
Common shares issued for cash,
net of issue costs |
| 50,985 | ||||||
Net cash provided by financing activities |
| 50,985 | ||||||
Investments: |
||||||||
Acquisition of property, plant and
equipment |
(6,449 | ) | (35,140 | ) | ||||
Restricted cash (note 7 (b)) |
(50,000 | ) | | |||||
Proceeds from sale of marketable
securities, net |
| 334,143 | ||||||
Net cash provided by (used in) investing
activities |
(56,449 | ) | 299,003 | |||||
Decrease in cash and cash
equivalents |
(584,953 | ) | (1,079,250 | ) | ||||
Cash and cash equivalents, beginning
of period |
995,106 | 3,000,615 | ||||||
Cash and cash equivalents, end of period |
$ | 410,153 | $ | 1,921,365 | ||||
Cash and cash equivalents are comprised of: |
||||||||
Cash |
$ | 410,153 | $ | 834,750 | ||||
Cash equivalents |
| 1,086,615 | ||||||
$ | 410,153 | $ | 1,921,365 | |||||
Supplemental cash flow information |
||||||||
Interest received |
$ | 9,766 | $ | 39,241 |
5
1. | Nature of business and future operations: | |
Triant Holdings Inc. (The Company) designs, develops and markets sophisticated equipment health monitoring and fault detection software solutions and related services for the global semiconductor and flat-panel display industries. The Company provides innovative solutions that enable its customers to lower the production costs in their state-of-the-art manufacturing facilities through a combination of improved yield and higher throughput. To address the market opportunity in these industries, the Company has developed ModelWare®, a complete software solution that major semiconductor and flat-panel display companies use (in a 24/7 environment) to provide them with a competitive advantage in the manufacture of their products. | ||
The accompanying unaudited consolidated financial statements include all information and footnote disclosures required under Canadian generally accepted accounting principles for interim financial statements. | ||
The unaudited consolidated balance sheets, statements of operations and other comprehensive income, shareholders equity and statements of cash flows have been prepared in accordance with Canadian generally accepted accounting principles. There are no material measurement differences between Canadian GAAP and U.S. GAAP for the six months ended June 30, 2008 see note 11. These financial statements follow the same accounting policies and methods of applications as the most recent annual consolidated financial statements dated December 31, 2007, except for new accounting policies adopted as disclosed in note 2. These financial statements should be read in conjunction with the annual consolidated financial statements and notes thereto for the fiscal year ended December 31, 2007. | ||
These financial statements have been prepared on a going concern basis notwithstanding the fact that the Company has reported net losses in four of its last five years of operation. The continuation of the Company as a going concern is dependent upon the attainment of profitable operations and upon the Companys continuing ability to raise sufficient additional financing as required. While management anticipates revenue from its current products and related services, there is no assurance that the Company will earn sufficient revenue to maintain its future operations. Consequently, the Company would have to raise additional funds in the future in order to maintain operations. There is no assurance that sufficient additional financing will be available. If such funds are unavailable or are not available on acceptable terms, the Company may be unable to maintain its future operations, take advantage of opportunities, develop new products or otherwise respond to competitive pressures. Certain conditions and events such as those described above may cast substantial doubt on the Companys ability to continue as a going concern. It is uncertain whether Triant can generate enough revenue in the near term to sustain its operations in the absence of additional financing, which is problematic given the current state of capital markets, or in the absence of corporate restructuring or concluding a strategic initiative. | ||
2. | Change in accounting policies: | |
Effective January 1, 2008, the Company adopted the new accounting standards related to financial instruments that were issued by the Canadian Institute of Chartered Accountants (CICA). These accounting policy changes were adopted on a prospective basis with no restatement of prior period financial statements. The new standards and accounting policy changes are as follows: |
6
2. | Change in accounting policies (continued): |
(a) | Inventories: | ||
In June 2007, the CICA issued new Handbook Section 3031, Inventories, which replaces CICA 3030, Inventories. This new standard requires inventories to be measured at the lower of cost and net realizable value, provides guidance on the determination of cost and requires the reversal of prior period write-downs when the net realizable value of impaired inventory subsequently recovers. The adoption of this standard had no material impact on the Companys unaudited interim consolidated financial statements. | |||
(b) | Capital disclosures: | ||
In December 2006, the CICA issued Handbook Section 1535, Capital Disclosures. This section requires an entity to disclose information to enable users of its financial statements to evaluate the entitys objectives, policies and processes for managing capital. This new disclosure is provided in note 8. | |||
(c) | Financial instruments disclosures and presentation: | ||
In December 2006, the CICA issued Handbook Section 3862, Financial Instruments - Disclosures, and Section 3863, Financial Instruments Presentation. These standards enhance existing disclosures in previously issued Section 3861, Financial Instruments - Disclosure and Presentation. Section 3862 describes the required disclosures relating to risks arising from recognized and unrecognized financial instruments and how those risks are managed. Section 3863 establishes standards for presentation of financial instruments and non-financial derivatives. The new disclosure requirements are presented in note 7. | |||
(d) | Financial statement presentation: | ||
In April 2007, the CICA Accounting Standards Board amended Section 1400, General Standards of Financial Statement Presentation. These amendments require management to disclose any uncertainties that cast significant doubt on the entitys ability to continue as a going concern. In assessing whether the going concern assumption is appropriate, management must take into account all available information about the future, which is at least, but is not limited to, 12 months from the balance sheet date. The additional disclosures required as a result of adopting these standards are included in note 1. |
3. | Inventory: | |
As at June 30, 2008, total inventory of $151,389 (December 31, 2007 $170,565) included work-in-progress inventory of $14,883 (December 31, 2007 $22,440), which is valued on a percentage of completion basis based on cost, and finished goods inventory of $136,506 (December 31, 2007 $148,125), which is valued at the lower of cost and estimated net realizable value. |
7
4. | Stock-based compensation expense: | |
The Company recorded a charge to earnings for stock-based compensation expense for the six months ended June 30, 2008 and 2007 for stock options granted to employees and directors based on a fair value approach using the Black-Scholes option pricing model. During the six months ended June 30, 2008, there were no stock options granted. Consequently, the option-pricing model assumptions and resulting stock option value per share are not applicable. The assumptions used and the resulting stock option valuations for the six months ended June 30, 2008 and 2007 are summarized as follows: |
Six months ended | ||||||||
June 30, | ||||||||
2008 | 2007 | |||||||
Stock-based compensation expense |
$ | 41,580 | $ | 52,783 | ||||
Option-pricing model assumptions: |
||||||||
Dividends paid |
N/a | Nil | ||||||
Expected volatility |
N/a | 167 | % | |||||
Expected life |
N/a | 3 years | ||||||
Risk-free interest rate |
N/a | 4.04 | % | |||||
Stock option value per share |
N/a | $ | 2.93 | |||||
5. | Changes in operating assets and liabilities: | |
The effect on cash flows from changes in operating assets and liabilities for the six months ended June 30, 2008 and 2007 are as follows: |
Six months ended | ||||||||
June 30, | ||||||||
2008 | 2007 | |||||||
Accounts receivable: |
||||||||
Trade |
$ | 72,330 | $ | 103,610 | ||||
Other |
71,444 | (13,035 | ) | |||||
Inventory |
19,176 | 758 | ||||||
Prepaid expenses and other |
36,247 | 122,946 | ||||||
Accounts payable |
(90,743 | ) | (55,444 | ) | ||||
Accrued liabilities |
511 | (436,651 | ) | |||||
Deferred revenue |
57,585 | (49,579 | ) | |||||
$ | 166,550 | $ | (327,395 | ) | ||||
8
6. | Segmented and other information: | |
The Company operates in one segment being developing and deploying equipment health monitoring and advanced fault detection solutions. | ||
Information related to geographical areas for the six months ended June 30, 2008 and 2007 are as follows: |
Six months ended | ||||||||
June 30, | ||||||||
2008 | 2007 | |||||||
Revenue: |
||||||||
Asia |
$ | 1,744,868 | $ | 1,455,757 | ||||
United States |
219,333 | 294,263 | ||||||
Europe |
42,670 | 81,704 | ||||||
$ | 2,006,871 | $ | 1,831,724 | |||||
7. | Financial instruments: | |
The Company, through its financial assets and liabilities, has exposure to the following risks from its use of financial instruments: credit risk, liquidity risk, and market risk. The following analysis provides a measurement of risks as at the balance sheet date of June 30, 2008. |
(a) | Credit risk: | ||
Credit risk is the risk of loss resulting from the failure of a customer or counterparty to meet its contractual obligations to the Company. The carrying amount of financial assets represents the Companys estimate of maximum credit exposure. | |||
The Companys principal financial assets are cash and cash equivalents and accounts receivable, which represent the Companys exposure to credit risk in relation to financial assets. | |||
The Companys credit risk is primarily attributable to its trade accounts receivable. The Company currently derives revenue primarily from a limited number of customers in the semiconductor industry. As these customers are generally major multinational corporations, credit risks on trade accounts receivable are considered to be minimal. Historically, the Company has not had any significant bad debts expense. For the six months ended June 30, 2008, the two largest customers of the Company accounted for 57% and 13% of revenue, respectively. Comparatively, for the six months ended June 30, 2007, the two largest customers of the Company accounted for 38% and 26% of revenue, respectively. |
9
7. | Financial instruments (continued): | |
The credit risk on cash and cash equivalents is limited because the counterparties are generally banks and corporations with high credit-ratings assigned by international credit-rating agencies. The Company invests its excess cash principally in money market funds and investment grade securities. The Company has established guidelines relative to diversification and maturities that maintain safety and liquidity. |
(b) | Liquidity risk: | ||
Liquidity risk is the risk that the Company will encounter difficulty in meeting obligations associated with its financial liabilities. The Company currently maintains liquidity through the generation of cash flows from operations and borrowing under existing line of credits, and believes these sources will be adequate to meet all future obligations. | |||
During the six months ended June 30, 2008, the Company maintained a $500,000 operating line of credit from HSBC Bank Canada under Export Development Canadas (EDC) Master Accounts Receivable Guarantee program. | |||
This credit facility bears interest at the banks prime rate plus 1.25% per annum and is secured by a general security agreement, a general assignment of book debts and Master Accounts Receivable Guarantee (MARG) program with Export Development Canada, an assignment of all risk insurance coverage and a cash term deposit of $50,000. At June 30, 2008, there was no balance outstanding on this credit facility. | |||
(c) | Market risk: | ||
Market risk arises from changes in market prices and rates (including interest rates, foreign exchange rates and equity prices), the correlations among them, and their levels of volatility. The objective of market risk management is to manage and control market risk exposures within acceptable parameters, while optimizing the return on risk. |
(i) | Currency Risk: | ||
The Company undertakes transactions denominated in foreign currencies (mainly in United States dollars) and as such is exposed to price risk due to fluctuations in foreign exchange rates. During the six months ended June 30, 2008 and 2007, 100% ($2,006,871) and 100% ($1,831,724) of the Companys revenue was denominated in United States dollars, respectively. At June 30, 2008 and December 31, 2007, 100% ($526,485) and 100% ($598,815) of trade accounts receivable were denominated in United States dollars, respectively. The Company does not use derivative instruments to reduce its exposure to foreign currency risk. |
10
7. | Financial instruments (continued): |
(d) | Fair Values and classification of financial instruments: | |
The fair values of financial assets and liabilities, together with the carrying amounts shown in the consolidated balance sheet are as follows: |
June 30, 2008 | December 31, 2007 | |||||||||||||||
(Unaudited) | (Audited) | |||||||||||||||
Carrying | Fair | Carrying | Fair | |||||||||||||
Amount | alue | Amount | Value | |||||||||||||
Cash and cash
equivalents (cash
equivalents are
measured at fair
value) |
$ | 410,153 | $ | 410,153 | $ | 995,106 | $ | 995,106 | ||||||||
Restricted cash |
50,000 | 50,000 | | | ||||||||||||
Trade and other
accounts receivable
measured at
amortized cost |
599,703 | 526,485 | 743,477 | 743,477 | ||||||||||||
Accounts payable
and accrued
liabilities
measured at
amortized cost |
301,908 | 301,908 | 392,140 | 392,410 | ||||||||||||
8. | Capital management: | |
The Companys objective is to increase its capital base so as to maintain investor, creditor and market confidence and to sustain current and future development of the business. This is accomplished by increasing the value of the Companys assets through internal growth and having that reflected in the share price. The Company considers the items included in the consolidated shareholders equity and the line of credit as capital and may issue new shares, draw on its line of credit or raise debt to maintain its capital structure. At this time the Company has not utilized its line of credit as part of its capital management program. The Company has no externally imposed capital requirements. |
11
9. | Related party transactions: | |
During the six months ended June 30, 2008 and 2007, the Company incurred expenses of $Nil and $11,900, respectively for consulting services from one of its non-management directors. | ||
10. | Future changes in accounting policies: | |
The CICA has announced several future changes in accounting policy which will affect the financial statements of the Company subsequent to June 30, 2008. The significant changes are as follows: |
(a) | Goodwill and Intangible Assets: | ||
In October 2007, the CICA approved Handbook Section 3064, Goodwill and Intangible Assets, which replaces the existing Handbook Sections 3062, Goodwill and Other Intangible Assets and 3450 Research and Development Costs. This standard is effective for the Companys interim and annual consolidated financial statements relating to fiscal years beginning on or after January 1, 2009. The standard provides guidance on the recognition, measurement and disclosure requirements for goodwill and intangible assets. The Company is currently assessing the impact of these new accounting standards on its consolidated financial statements. | |||
(b) | International financial reporting standards: | ||
The Accounting Standards Board (AcSB) establishes financial accounting and reporting standards for use by Canadian companies. It also participates in the development of internationally accepted accounting standards. The AcSB is accountable to the Accounting Standards Oversight Council, an independent body established in September 2000 by the CICA. On February 13, 2008, the AcSB announced the use of International Financial Reporting Standards (IFRS) will be required for fiscal years beginning on or after January 1, 2011 for publicly accountable profit-oriented enterprises including listed companies. IFRS will replace Canadas current GAAP. Companies will be required to provide comparative IFRS information for the previous fiscal year. The Company is currently assessing the impact of the adoption of IFRS on its consolidated financial statements. |
11. | Differences between Canadian GAAP and U.S. GAAP: | |
The consolidated financial statements have been prepared in accordance with Canadian GAAP which, as applied by the Company, differ in certain significant respects from accounting principles generally accepted in the United States of America (US GAAP). Under US GAAP, when computing the stock compensation expense under Statement of Financial Accounting Standard No. 123 (revised 2004), Share-Based Payment, the Company is required to estimate the forfeitures when the awards are granted whereas the Company, as allowed under Canadian GAAP, opted to recognize forfeitures as they occurred. The Company has reviewed the impact of the accounting differences between Canadian and US GAAP and concluded that the impact was immaterial for all presented periods. | ||
12. | Subsequent Event: | |
On August 27, 2008, the Company announced that it had entered into an agreement to sell substantially all of the assets of Triant Technologies, Inc. to PDF Solutions, Inc., a company based in San Jose, CA, United |
12
13
/s/ KPMG LLP
|
||
Chartered Accountants |
14
2007 | 2006 | |||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 995,106 | $ | 3,000,615 | ||||
Accounts receivable: |
||||||||
Trade |
598,815 | 1,057,204 | ||||||
Other |
144,662 | 177,401 | ||||||
Inventory (note 3(a)) |
170,565 | 203,385 | ||||||
Prepaid expenses and other |
183,408 | 272,874 | ||||||
2,092,556 | 4,711,479 | |||||||
Property, plant and equipment (note 3(b)) |
183,643 | 166,506 | ||||||
$ | 2,276,199 | $ | 4,877,985 | |||||
Liabilities and Shareholders Equity |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 109,718 | $ | 179,273 | ||||
Accrued liabilities (note 3(c)) |
282,422 | 739,829 | ||||||
Deferred revenue |
146,582 | 606,886 | ||||||
538,722 | 1,525,988 | |||||||
Shareholders equity: |
||||||||
Capital stock: |
||||||||
Preferred shares: |
||||||||
Authorized: No maximum, without par value
Issued and outstanding: December 31, 2007 and
December 31, 2006 - nil |
||||||||
Common shares: |
||||||||
Authorized: No maximum, without par value
Issued and outstanding: December 31, 2007 - 4,170,399 and
December 31, 2006 - 4,140,789 |
36,809,322 | 36,739,395 | ||||||
Contributed surplus |
3,399,100 | 3,306,606 | ||||||
Deficit |
(38,470,945 | ) | (36,694,004 | ) | ||||
1,737,477 | 3,351,997 | |||||||
$ | 2,276,199 | $ | 4,877,985 | |||||
/s/ Robert Heath
|
Director | /s/ Richard B. Grogan | Director | |||
Robert Heath
|
Richard B. Grogan |
15
2007 | 2006 | |||||||
Revenue: |
||||||||
Licenses and products |
$ | 924,853 | $ | 3,310,434 | ||||
Services and maintenance |
2,764,898 | 3,020,273 | ||||||
3,689,751 | 6,330,707 | |||||||
Cost of revenue |
1,071,921 | 1,630,372 | ||||||
Gross margin |
2,617,830 | 4,700,335 | ||||||
Operating expenses: |
||||||||
Selling, general and administrative |
2,559,347 | 2,722,057 | ||||||
Research and development |
2,033,230 | 1,971,134 | ||||||
4,592,577 | 4,693,191 | |||||||
Earnings (loss) from operations |
(1,974,747 | ) | 7,144 | |||||
Interest and other income |
64,955 | 95,869 | ||||||
Foreign exchange gains (losses) |
(201,292 | ) | 37,559 | |||||
Gain on sale of marketable securities (note 10) |
334,143 | | ||||||
Gain on dilution of subsidiary interest (note 10) |
| 950,000 | ||||||
Net earnings (loss) and comprehensive income (loss) for the year |
$(1,776,941) | $ | 1,090,572 | |||||
Earnings (loss) per common share (note 11): |
||||||||
Basic |
$ | (0.43 | ) | $ | 0.26 | |||
Diluted |
(0.43 | ) | 0.26 | |||||
Weighted average number of common shares outstanding (note 11): |
||||||||
Basic |
4,164,254 | 4,140,789 | ||||||
Diluted |
4,164,254 | 4,208,003 | ||||||
16
Common shares | Contributed | |||||||||||||||||||
Shares | Amount | surplus | Deficit | Total | ||||||||||||||||
Balance, December 31, 2005 |
4,140,789 | $ | 36,739,395 | $ | 3,149,493 | $ | (37,784,576 | ) | $ | 2,104,312 | ||||||||||
Stock-based compensation (note 2(k)) |
| | 157,113 | | 157,113 | |||||||||||||||
Net earnings for the year |
| | | 1,090,572 | 1,090,572 | |||||||||||||||
Balance, December 31, 2006 |
4,140,789 | 36,739,395 | 3,306,606 | (36,694,004 | ) | 3,351,997 | ||||||||||||||
Issued for cash: |
||||||||||||||||||||
Exercises of stock options |
29,610 | 50,985 | | | 50,985 | |||||||||||||||
Transfer from contributed surplus
to share capital on exercise of options |
| 18,942 | (18,942 | ) | | | ||||||||||||||
Stock-based compensation (note 2(k)) |
| | 111,436 | | 111,436 | |||||||||||||||
Net loss and other comprehensive
income for the year |
| | | (1,776,941 | ) | (1,776,941 | ) | |||||||||||||
Balance, December 31, 2007 |
4,170,399 | $ | 36,809,322 | $ | 3,399,100 | $ | (38,470,945 | ) | $ | 1,737,477 | ||||||||||
17
2007 | 2006 | |||||||
Cash provided by (used in): |
||||||||
Operations: |
||||||||
Net earnings (loss) and comprehensive income (loss) for the year |
$ | (1,776,941 | ) | $ | 1,090,572 | |||
Items not affecting cash: |
||||||||
Amortization |
50,978 | 49,065 | ||||||
Stock-based compensation (note 2(k)) |
111,436 | 157,113 | ||||||
Gain on sale of marketable securities (note 10) |
(334,143 | ) | | |||||
Gain on dilution of subsidiary interest (note 10) |
| (950,000 | ) | |||||
Changes in operating assets and liabilities (note 5) |
(373,852 | ) | (1,182,176 | ) | ||||
Net cash (used in) operating activities |
(2,322,522 | ) | (835,426 | ) | ||||
Financing: |
||||||||
Common shares issued for cash, net of issue costs |
50,985 | | ||||||
Net cash provided by financing activities |
50,985 | | ||||||
Investments: |
||||||||
Acquisition of property, plant and equipment |
(68,115 | ) | (45,984 | ) | ||||
Proceeds from sale of marketable securities, net (note 10) |
334,143 | | ||||||
Proceeds from dilution of subsidiary interest, net (note 10) |
| 950,000 | ||||||
Net cash provided by investing activities |
266,028 | 904,016 | ||||||
Increase (decrease) in cash and cash equivalents |
(2,005,509 | ) | 68,590 | |||||
Cash and cash equivalents, beginning of year |
3,000,615 | 2,932,025 | ||||||
Cash and cash equivalents, end of year |
$ | 995,106 | $ | 3,000,615 | ||||
Cash and cash equivalents are comprised of: |
||||||||
Cash |
$ | 995,106 | $ | 1,208,640 | ||||
Cash equivalents |
| 1,791,975 | ||||||
$ | 995,106 | $ | 3,000,615 | |||||
18
(a) | Consolidation: | ||
These consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany transactions have been eliminated upon consolidation. | |||
(b) | Foreign exchange: | ||
The Companys functional currency is the Canadian dollar. The accounts of the Company and its subsidiaries are expressed in Canadian dollars. Monetary assets and liabilities denominated in other than the Canadian dollar are translated into Canadian dollars at the exchange rates in effect at the balance sheet dates. Other balance sheet items and revenues and expenses are translated at the rates prevailing on the respective transaction dates. Translation gains and losses relating to monetary items are included in operations. |
19
(c) | Use of estimates: | ||
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities at the date of the financial statements and for the periods presented. Estimates are used for, but not limited to, determining the allowance for doubtful accounts, determination of the net recoverable amount of property, plant and equipment, compensation accruals, warranty provision, determination of the fair value of multiple element revenue arrangements (including installation periods), amortization, stock-based compensation, income taxes, and contingencies. Actual results may differ from those estimates. | |||
(d) | Cash and cash equivalents: | ||
The Company invests certain of its excess cash in cash equivalents which are highly liquid money market instruments with an original maturity of 90 days or less. | |||
(e) | Inventory: | ||
Inventory is valued at the lower of cost and estimated net realizable value. | |||
(f) | Research and development costs: | ||
Research costs are expensed when incurred. Development costs are capitalized to the extent that recovery of these costs is reasonably assured, and are amortized over the life of the related product. No development costs have been capitalized as at December 31, 2007 and 2006. | |||
(g) | Property, plant and equipment: | ||
Property, plant and equipment are recorded at cost and amortized over the estimated useful lives of the assets on the following bases: |
Computer hardware and software
|
30% per annum declining balance basis | |
Furniture and equipment
|
20% per annum declining balance basis | |
Leasehold improvements
|
straight-line over the lesser of the lease term and the useful life of the improvement |
The Company periodically evaluates the recoverability of its property, plant and equipment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss would be recognized when estimates of future cash flows expected to result from the use of an asset and its eventual disposition are less than its carrying amount. During the years ended December 31, 2007 and 2006, no impairment of property, plant and equipment was identified by the Company. |
20
(h) | Revenue recognition: | ||
The Companys revenue is derived from the following sources: |
(i) | Licenses, products, and services: | ||
Revenues from software license agreements are recognized upon delivery of software if persuasive evidence of an arrangement exists, collection is probable, the fee is fixed or determinable, and vendor-specific objective evidence exists to allocate the total fee to elements of the arrangement. Vendor-specific objective evidence is typically based on the price charged when an element is sold separately, or, in the case of an element not yet sold separately, the price established by authorized management, if it is probable that the price, once established, will not change before market introduction. Elements included in multiple element arrangements could consist of software products, upgrades, enhancements, or customer support services. If an acceptance period is required, revenues are recognized upon the earlier of customer acceptance or the expiration of the acceptance period. The Companys agreements with its customers, value-added resellers and distributors do not contain product return rights (except for product defects). | |||
Service revenues are primarily related to training and customer support services performed on a time-and-materials basis under separate service arrangements related to the use of the Companys products. Revenues from services are recognized as services are performed. | |||
If a transaction includes both license and service elements, license fee revenues are recognized on shipment of the software, provided that services do not include significant customization or modification of the base product, and the payment terms for licenses are not subject to acceptance criteria. Where installation services are essential to the functionality of the base product, then revenue is recognized on a percentage of completion basis over the period of installation. In cases where license fee payments are contingent on acceptance of services, the Company defers recognition of revenues from both the license and the service elements until the acceptance criteria are met. | |||
(ii) | Maintenance: | ||
Revenue related to maintenance agreements for supporting and maintaining the Companys products is recognized ratably over the term of the agreement, generally one year. Where the Company enters into arrangements for the sale of software licenses and maintenance, the Company accounts for such transactions as multiple element arrangements and allocates the consideration received to each element, based on vendor specific objective evidence of the price charged for elements separately. As a result, revenues recognized from maintenance and license agreements may vary depending on the allocation determined by the Company. |
21
(i) | Cost of revenue: | ||
Cost of revenue consists primarily of commissions, salaries and benefits, travel, allocated overhead costs, warranty, freight and brokerage and other costs directly associated with revenue. | |||
(j) | Warranty: | ||
A provision for potential warranty claims is provided for at the time that the sale is recognized based on warranty terms and prior experience and is included in cost of revenue. | |||
(k) | Stock-based compensation: | ||
The Company recorded a charge to earnings for stock-based compensation expense for the years ended December 31, 2007 and 2006 for stock options granted to employees and directors based on a fair value approach using the Black-Scholes option pricing model. The assumptions used and the resulting stock option valuations for the years ended December 31, 2007 and 2006 are as follows: |
2007 | 2006 | |||||||
Stock-based compensation expense |
$ | 111,436 | $ | 157,113 | ||||
Option-pricing model assumptions: |
||||||||
Dividends paid |
Nil | Nil | ||||||
Expected volatility |
106 | % | 140 | % | ||||
Expected life |
3 years | 3 years | ||||||
Risk-free interest rate |
4.04 | % | 4.16 | % | ||||
Stock option value per share |
$ | 1.37 | $ | 0.46 | ||||
(l) | Income taxes: | ||
Future income taxes relate to the expected future tax consequences of differences between the carrying amount of balance sheet items and their corresponding tax values. Future tax assets, if any, are recognized only to the extent that, in the opinion of management, it is more likely than not that the future income tax assets will be realized. Future income tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment or substantive enactment. | |||
(m) | Earnings (loss) per common share: | ||
Basic earnings (loss) per share is computed using the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed using the weighted average number of common and common equivalent shares outstanding during the period using the treasury stock method. Common equivalent shares consist of the incremental common shares issuable upon the exercise of stock options and warrants unless their effect is antidilutive (see also Note 11). |
22
(n) | Financial Instruments: | ||
Effective January 1, 2007, the Company adopted the new accounting standards related to financial instruments that were issued by the Canadian Institute of Chartered Accountants (CICA). These accounting policy changes were adopted on a prospective basis with no restatement of prior period financial statements. The new standards and accounting policy changes are as follows: |
(i) | Comprehensive income (CICA Handbook Section 1530): | ||
Comprehensive income is the change in shareholders equity during a period from transactions and other events and circumstances from non-owner sources. In accordance with this new standard, the Company reports a consolidated statement of comprehensive income and a new category, accumulated other comprehensive income, is added to the shareholders equity section of the consolidated balance sheet for any unrealized gains and losses on financial assets classified as available for sale. The Company had no other comprehensive income or loss transactions during the year ended December 31, 2007 and no opening or closing balances for accumulated comprehensive income or loss. | |||
(ii) | Financial instruments recognition and measurement (CICA Handbook Section 3855) and disclosure and presentation (CICA Handbook Section 3861): | ||
In accordance with these new standards, the Company now classifies all financial instruments as either held-for-trading, available for sale, held-to-maturity, loans and receivables or other financial liabilities. Financial instruments classified as held-for-trading are measured at fair value with unrealized gains and losses recognized in operating results. Financial instruments classified as available for sale are measured at fair value with unrealized gains and losses recognized in other comprehensive income. Financial instruments classified as held-to-maturity, loans and receivables or other financial liabilities are measured at amortized cost. | |||
Upon adoption of these new standards, the Company has designated its cash and cash equivalents as held-for-trading, which are measured at fair value. Accounts receivable are classified as loans and receivables, which are measured at amortized cost. Accounts payable and accrued liabilities are classified as other liabilities, which are measured at amortized cost. | |||
During the year ended December 31, 2007, the Company had neither available for sale nor held-to-maturity financial instruments. |
23
(a) | Inventory: |
2007 | 2006 | |||||||
Work-in-progress |
$ | 22,440 | $ | 55,858 | ||||
Finished goods |
148,125 | 147,527 | ||||||
$ | 170,565 | $ | 203,385 | |||||
(b) | Property, plant and equipment: |
Accumulated | Net book | |||||||||||
2007 | Cost | amortization | value | |||||||||
Computer hardware and software |
$ | 389,208 | $ | 222,872 | $ | 166,336 | ||||||
Furniture and equipment |
29,400 | 21,159 | 8,241 | |||||||||
Leasehold improvements |
28,090 | 19,024 | 9,066 | |||||||||
$ | 446,698 | $ | 263,055 | $ | 183,643 | |||||||
Accumulated | Net book | |||||||||||
2006 | Cost | amortization | value | |||||||||
Computer hardware and software |
$ | 319,911 | $ | 176,380 | $ | 143,531 | ||||||
Furniture and equipment |
30,821 | 19,178 | 11,643 | |||||||||
Leasehold improvements |
28,090 | 16,758 | 11,332 | |||||||||
$ | 378,822 | $ | 212,316 | $ | 166,506 | |||||||
(c) | Accrued liabilities: |
2007 | 2006 | |||||||
Compensation payable |
$ | 86,302 | $ | 556,827 | ||||
Warranty provision |
50,000 | 50,000 | ||||||
Other |
146,120 | 133,002 | ||||||
$ | 282,422 | $ | 739,829 | |||||
24
(a) | Shareholder rights plan: | ||
The Company has a Shareholder Rights Plan, which is intended to provide the Board of Directors (the Board) of the Company and its shareholders with a reasonable period of time to fully consider any unsolicited take-over bid. It also provides the Board with more time to consider and pursue, if appropriate, other alternatives for the purpose of maximizing shareholder value. At the Companys annual general meeting of shareholders held on June 20, 2007, the shareholders approved the extension of the expiration time of this plan for a further five years from February 21, 2008 to February 21, 2013. This plan has one remaining five-year renewal option subject to shareholders approval. | |||
(b) | Stock-based compensation: |
(i) | 2005 Share incentive plan: | ||
The Share Incentive Plan provides for equity participation in the Company by its directors, officers, employees and consultants through the grant of stock options to purchase common shares of the Company and through the grant of bonuses payable in common shares of the Company. This plan, as approved by the shareholders, authorizes the directors to grant stock options and bonus shares within the limitations of this plan and subject to the rules of applicable regulatory authorities. The exercise price of stock options granted under this plan is at not less than fair market value as approved by the Toronto Stock Exchange, and the price of bonus shares is at market. The stock options generally may be exercisable for a period of up to five years and generally vest over three years. At the Companys annual general meeting of shareholders held on June 20, 2007, the shareholders approved the elimination of the June 26, 2007 expiry date of this plan and certain other amendments to this plan. | |||
At December 31, 2007, the Company had 202,420 common shares available for future grants of stock options. |
25
(b) | Stock-based compensation (continued): |
(i) | 2005 Share incentive plan (continued): | ||
The following table summarizes the status of stock options at December 31, 2007 and 2006 and the changes during the years then ended: |
2007 | 2006 | |||||||||||||||
Weighted | Weighted | |||||||||||||||
average | average | |||||||||||||||
Number | exercise | Number | exercise | |||||||||||||
of shares | price | of shares | price | |||||||||||||
Outstanding, beginning of year |
444,850 | $ | 2.00 | 475,700 | $ | 4.95 | ||||||||||
Granted |
119,250 | 2.09 | 187,000 | 0.63 | ||||||||||||
Exercised |
(29,610 | ) | 1.72 | | | |||||||||||
Lapsed |
(98,540 | ) | 2.73 | (217,850 | ) | 7.27 | ||||||||||
Outstanding, end of year |
435,950 | $ | 1.88 | 444,850 | $ | 2.00 | ||||||||||
Exercisable, end of year |
312,200 | $ | 2.06 | 268,600 | $ | 2.82 | ||||||||||
The following table summarizes information about stock options outstanding and exercisable at December 31, 2007: |
Weighted | Weighted | Weighted | ||||||||||||||||||
average | Number of | average | Number of | average | ||||||||||||||||
Exercise | remaining years | options | exercise | options | exercise | |||||||||||||||
price range | of contractual life | outstanding | price | exercisable | price | |||||||||||||||
$0.49 to $0.90 |
3.8 | 184,500 | $ | 0.59 | 97,850 | $ | 0.61 | |||||||||||||
$1.10 to $1.80 |
2.2 | 120,200 | 1.50 | 116,300 | 1.51 | |||||||||||||||
$2.40 to $3.75 |
3.3 | 78,500 | 3.39 | 45,300 | 3.23 | |||||||||||||||
$4.00 to $6.50 |
1.0 | 52,750 | 4.98 | 52,750 | 4.98 | |||||||||||||||
2.9 | 435,950 | $ | 1.88 | 312,200 | $ | 2.06 | ||||||||||||||
26
2007 | 2006 | |||||||
Accounts receivable: |
||||||||
Trade |
$ | 458,389 | $ | (784,105 | ) | |||
Other |
32,739 | (162,627 | ) | |||||
Inventory |
32,820 | (54,720 | ) | |||||
Prepaid expenses and other |
89,466 | (13,876 | ) | |||||
Accounts payable |
(69,555 | ) | (304,060 | ) | ||||
Accrued liabilities |
(457,407 | ) | 119,500 | |||||
Deferred revenue |
(460,304 | ) | 17,712 | |||||
$ | (373,852 | ) | $ | (1,182,176 | ) | |||
2007 | 2006 | |||||||
Revenue: |
||||||||
Asia |
$ | 2,871,301 | $ | 5,049,863 | ||||
United States |
541,767 | 1,042,990 | ||||||
Europe |
276,683 | 237,854 | ||||||
$ | 3,689,751 | $ | 6,330,707 | |||||
27
2007 | 2006 | |||||||
Canadian basic statutory rate |
34.12 | % | 34.12 | % | ||||
Expected income tax expense (recovery) |
$ | (606,292 | ) | $ | 372,103 | |||
Permanent and other differences |
54,249 | 26,653 | ||||||
Gain on dilution of subsidiary interest (note 10) |
| (324,140 | ) | |||||
Utilization of prior year losses |
| (74,616 | ) | |||||
Change in valuation allowance |
552,043 | | ||||||
$ | | $ | | |||||
2007 | 2006 | |||||||
Future income tax assets: |
||||||||
Tax loss carryforwards |
$ | 594,505 | $ | 74,617 | ||||
Research and development expenses |
| | ||||||
Book and tax base differences on assets |
57,489 | 25,334 | ||||||
Valuation allowance for future income tax assets |
(651,994 | ) | (99,951 | ) | ||||
Net future income tax assets |
$ | | $ | | ||||
28
2008 |
$ | 153,986 | ||
2009 |
153,986 | |||
2010 |
64,161 | |||
$ | 372,133 | |||
(a) | Fair value: | ||
The Company has financial instruments which include cash and cash equivalents, accounts receivable, deposits and accounts payable. The carrying value of cash and cash equivalents, accounts receivable, deposits and accounts payable approximates fair value at December 31, 2007 and 2006. | |||
(b) | Concentration of credit risk and economic dependence: | ||
The Company currently derives revenue primarily from a limited number of customers in the semiconductor industry. As these customers are generally major multinational corporations, credit risks are considered to be minimal. Historically, the Company has not had any significant bad debts expense. For the year ended December 31, 2007, the two largest customers of the Company account for 33% (56% in 2006) and 29% (21% in 2006) of revenue, respectively. The Company invests its excess cash principally in money market funds and investment grade securities. The Company has established guidelines relative to diversification and maturities that maintain safety and liquidity. | |||
(c) | Price risk: | ||
The Company undertakes transactions denominated in foreign currencies (mainly in United States dollars) and as such is exposed to price risk due to fluctuations in foreign exchange rates. During the year ended December 31, 2007 and 2006, 97% ($3,582,251) and 100% ($6,330,707) of the Companys revenue was denominated in United States dollars, respectively. At December 31, 2007 and 2006, 100% ($598,815) and 99.7% ($1,053,959) of trade accounts receivable were denominated in United States dollars, respectively. The Company does not use derivative instruments to reduce its exposure to foreign currency risk. |
29
Cash received from Technologies |
$ | 1,250,000 | ||
Less transaction costs |
(300,000 | ) | ||
Gain on dilution of subsidiary interest |
$ | 950,000 | ||
30
2007 | 2006 | |||||||
Basic total weighted average common shares outstanding |
4,164,254 | 4,140,789 | ||||||
Effect of dilutive securities: |
||||||||
Exercise of stock options |
| 67,214 | ||||||
Diluted total weighted average common shares outstanding |
4,164,254 | 4,208,003 | ||||||
31
(a) | Inventories: | ||
In June 2007, the CICA issued new Handbook Section 3031, Inventories, which replaces CICA 3030, Inventories. The new standard requires inventory to be measured at the lower of cost or net realizable value and requires any write-downs to be reversed if the value subsequently recovers, provides expanded guidance on the determination of cost, including the allocation of overhead and expands disclosures. The Company will adopt this new standard effective January 1, 2008, and does not expect the financial statements to be materially affected. | |||
(b) | Capital disclosures: | ||
In December 2006, the CICA issued Handbook Section 1535, Capital Disclosures. This section establishes standards for disclosing information about an entitys objectives, policies and processes for managing capital. This standard is effective for interim and annual financial statements relating to fiscal years commencing on or after October 1, 2007 on a prospective basis. The Company will adopt this new standard effective January 1, 2008, and does not expect the financial statements to be materially affected. |
32
(c) | Financial instruments disclosures and presentation: | ||
In December 2006, the CICA issued Handbook Section 3862, Financial Instruments Disclosures, and Section 3863, Financial Instruments Presentation. These standards enhance existing disclosures in previously issued Section 3861, Financial Instruments Disclosure and Presentation. Section 3862 places greater emphasis on disclosures about risks related to recognized and unrecognized financial instruments and how those risks are managed. Section 3863 carries forward the same presentation standards as Section 3861. These new standards are effective for interim and annual financial statements relating to fiscal years commencing on or after October 1, 2007 on a prospective basis. The Company will adopt this new standard effective January 1, 2008, and does not expect the financial statements to be materially affected. | |||
(d) | Financial statement presentation: | ||
In April 2007, the CICA Accounting Standards Board amended Section 1400, General Standards of Financial Statement Presentation. These amendments require management to disclose any uncertainties that cast significant doubt on the entitys ability to continue as a going concern. In assessing whether the going concern assumption is appropriate, management must take into account all available information about the future, which is at least, but is not limited to, 12 months from the balance sheet date. The Company will adopt this new standard effective January 1, 2008 on a prospective basis, and does not expect the financial statements to be materially affected. | |||
(e) | International financial reporting standards: | ||
The Accounting Standards Board (AcSB) establishes financial accounting and reporting standards for use by Canadian companies. It also participates in the development of internationally accepted accounting standards. The AcSB is accountable to the Accounting Standards Oversight Council, an independent body established in September 2000 by the CICA. On February 13, 2008, the AcSB announced the use of International Financial Reporting Standards (IFRS) will be required for fiscal years beginning on or after January 1, 2011 for publicly accountable profit-oriented enterprises including listed companies. IFRS will replace Canadas current GAAP. Companies will be required to provide comparative IFRS information for the previous fiscal year. The Company is evaluating the impact of the adoption of IFRS. |
33
1
Historical | Proforma | |||||||||||||||
Triant | Adjustments | Combined | ||||||||||||||
Assets |
||||||||||||||||
Current assets: |
||||||||||||||||
Cash and cash equivalents |
$ | 30,487 | $ | 455 | $ | (1,604 | ) (1) | $ | 28,883 | |||||||
(455 | ) (3) | |||||||||||||||
Short-term investments |
12,708 | | | 12,708 | ||||||||||||
Accounts receivable, net of allowance for doubtful accounts |
35,506 | 521 | (521 | ) (3) | 35,506 | |||||||||||
Prepaid expenses and other current assets |
3,771 | 368 | 55 | (2) | 3,826 | |||||||||||
(368 | ) (3) | |||||||||||||||
Deferred tax asset, current |
1,514 | | | 1,514 | ||||||||||||
Total current assets |
83,986 | 1,344 | (2,893 | ) | 82,437 | |||||||||||
Property and equipment, net |
3,344 | 160 | 16 | (2) | 3,360 | |||||||||||
(160 | ) (3) | |||||||||||||||
Non-current investments |
1,262 | | | 1,262 | ||||||||||||
Goodwill |
67,264 | | 216 | (1) | 67,480 | |||||||||||
Intangible assets, net |
11,184 | | 1,650 | (1) | 12,834 | |||||||||||
Deferred tax assets, non-current, and other assets |
10,825 | | | 10,825 | ||||||||||||
Total assets |
$ | 177,865 | $ | 1,504 | $ | (1,171 | ) | $ | 178,198 | |||||||
Liabilities and Stockholders Equity | ||||||||||||||||
Current portion of long-term debt |
$ | 418 | $ | | $ | | $ | 418 | ||||||||
Accounts payable |
2,378 | 19 | (19 | ) (3) | 2,378 | |||||||||||
Accrued compensation and benefits |
6,574 | 280 | (280 | ) (3) | 6,574 | |||||||||||
Other accrued liabilities |
2,253 | | 315 | (6) | 2,568 | |||||||||||
Taxes payable |
75 | | | 75 | ||||||||||||
Deferred revenues |
3,600 | 202 | 18 | (2) | 3,618 | |||||||||||
(202 | ) (3) | |||||||||||||||
Billings in excess of recognized revenue |
110 | | | 110 | ||||||||||||
Total current liabilities |
15,408 | 501 | (168 | ) | 15,741 | |||||||||||
Long-term debt |
911 | | | 911 | ||||||||||||
Long-term taxes payable |
5,670 | | | 5,670 | ||||||||||||
Other liabilities |
724 | | | 724 | ||||||||||||
Total liabilities |
22,713 | 501 | (168 | ) | 23,046 | |||||||||||
Common stock |
4 | | | 4 | ||||||||||||
Additional paid-in-capital |
185,333 | 36,404 | (36,404 | ) (3) | 185,333 | |||||||||||
Treasury stock at cost, 1,670 shares at June 30, 2008 |
(14,135 | ) | | | (14,135 | ) | ||||||||||
Accumulated deficit |
(21,345 | ) | (38,804 | ) | 38,804 | (3) | (21,345 | ) | ||||||||
Cumulative other comprehensive income (loss) |
5,295 | 3,403 | (3,403 | ) (3) | 5,295 | |||||||||||
Total stockholders equity |
155,152 | 1,003 | (1,003 | ) | 155,152 | |||||||||||
Total liabilities and stockholders equity |
$ | 177,865 | $ | 1,504 | $ | (1,171 | ) | $ | 178,198 | |||||||
2
Six months ended June 30, 2008 | ||||||||||||||||
Historical | Pro Forma | |||||||||||||||
Triant | Adjustments | Combined | ||||||||||||||
Design-to-silicon-yield solutions |
$ | 30,476 | $ | 1,992 | $ | | $ | 32,468 | ||||||||
Gainshare performance incentives |
10,985 | | 10,985 | |||||||||||||
Revenues |
41,461 | 1,992 | 43,453 | |||||||||||||
Costs and expenses: |
||||||||||||||||
Costs of revenues |
||||||||||||||||
Direct costs of design-to-silicon-yield solutions: |
15,033 | 564 | 15,597 | |||||||||||||
Amortization of acquired core technology |
1,262 | | 105 | (4) | 1,367 | |||||||||||
Total cost of design-to-silicon-yield solutions |
16,295 | 564 | 105 | 16,964 | ||||||||||||
Gross margin |
25,166 | 1,428 | (105 | ) | 26,489 | |||||||||||
Operating expenses: |
||||||||||||||||
Research and development |
18,210 | 955 | 19,165 | |||||||||||||
Selling, general and administrative |
11,945 | 1,257 | 13,202 | |||||||||||||
Amortization of intangible assets |
389 | | 206 | (4) | 595 | |||||||||||
Restructuring charges |
1,471 | | | 1,471 | ||||||||||||
Total operating expenses |
32,015 | 2,212 | 206 | 34,433 | ||||||||||||
Income (loss) from operations |
(6,849 | ) | (784 | ) | (311 | ) | (7,944 | ) | ||||||||
Interest and other income, net |
740 | 26 | (24 | )(7) | 742 | |||||||||||
Income (loss) before taxes |
(6,109 | ) | (758 | ) | (335 | ) | (7,202 | ) | ||||||||
Tax provision (benefit) |
(1,656 | ) | | (134 | )(5) | (1,790 | ) | |||||||||
Net income (loss) |
$ | (4,453 | ) | $ | (758 | ) | $ | (201 | ) | $ | (5,412 | ) | ||||
Net income per share: |
||||||||||||||||
Basic |
$ | (0.16 | ) | $ | (0.20 | ) | ||||||||||
Diluted |
$ | (0.16 | ) | $ | (0.20 | ) | ||||||||||
Weighted average common shares: |
||||||||||||||||
Basic |
27,724 | 27,724 | ||||||||||||||
Diluted |
27,724 | 27,724 | ||||||||||||||
3
Year ended December 31, 2007 | ||||||||||||||||
Historical | Pro Forma | |||||||||||||||
Triant | Adjustments | Combined | ||||||||||||||
Design-to-silicon-yield solutions |
$ | 70,376 | $ | 3,434 | $ | | $ | 73,810 | ||||||||
Gainshare performance incentives |
24,087 | | 24,087 | |||||||||||||
Revenues |
94,463 | 3,434 | 97,897 | |||||||||||||
Costs and expenses: |
||||||||||||||||
Costs of revenues |
||||||||||||||||
Direct costs of design-to-silicon-yield solutions: |
32,470 | 998 | 33,468 | |||||||||||||
Amortization of acquired core technology |
5,148 | | 210 | (4) | 5,358 | |||||||||||
Total cost of design-to-silicon-yield solutions |
37,618 | 998 | 210 | 38,826 | ||||||||||||
Gross margin |
56,845 | 2,436 | (210 | ) | 59,071 | |||||||||||
Operating expenses: |
||||||||||||||||
Research and development |
36,074 | 1,892 | 37,966 | |||||||||||||
Selling, general and administrative |
24,891 | 2,382 | 27,273 | |||||||||||||
Amortization of intangible assets |
3,422 | | 353 | (4) | 3,775 | |||||||||||
Restructuring charges |
| | | | ||||||||||||
Total operating expenses |
64,387 | 4,274 | 353 | 69,014 | ||||||||||||
Income (loss) from operations |
(7,542 | ) | (1,838 | ) | (563 | ) | (9,943 | ) | ||||||||
Interest and other income, net |
1,891 | 184 | (48 | )(7) | 2,027 | |||||||||||
Income (loss) before taxes |
(5,651 | ) | (1,654 | ) | (611 | ) | (7,916 | ) | ||||||||
Tax provision (benefit) |
(2,724 | ) | | (244 | )(5) | (2,968 | ) | |||||||||
Net income (loss) |
$ | (2,927 | ) | $ | (1,654 | ) | $ | (367 | ) | $ | (4,948 | ) | ||||
Net income per share: |
||||||||||||||||
Basic |
$ | (0.10 | ) | $ | (0.18 | ) | ||||||||||
Diluted |
$ | (0.10 | ) | $ | (0.18 | ) | ||||||||||
Weighted average common shares: |
||||||||||||||||
Basic |
28,066 | 28,066 | ||||||||||||||
Diluted |
28,066 | 28,066 | ||||||||||||||
4
Cash paid for purchase |
$ | 1,604 | (a) | |
Transaction costs |
315 | |||
Total purchase price |
$ | 1,919 | ||
Cash paid to Triant |
$ | 1,230 | ||
Cash paid to escrow account |
374 | |||
Total cash paid for purchase |
$ | 1,604 | ||
Estimated | ||||||||
Preliminary Allocation of purchase price: | Useful Life (Yrs). | |||||||
Allocation of purchase price: |
||||||||
Fair value of tangible assets |
$ | 71 | ||||||
Developed / Core technology |
2 | 420 | ||||||
Customer relationships |
4 | 1,170 | ||||||
Contract backlog |
.25 | 60 | ||||||
Goodwill |
N/A | 216 | ||||||
Total assets acquired |
1,937 | |||||||
Deferred revenue |
(18 | ) | ||||||
Total liabilities assumed |
(18 | ) | ||||||
Total consideration |
$ | 1,919 | ||||||
5
Estimated Useful | ||||
Life (years) | ||||
Developed / Core technology |
2 | |||
Customer relationships |
4 | |||
Contract backlog |
.25 |
6